Carbenoxolone as a novel therapy for attenuation of cancer-induced bone pain

Cancer PainChronic Pain

Effect of Peritumoral Bupivacaine on Primary and Distal Hyperalgesia in Cancer-Induced Bone Pain

J Pain Res.

Mathew SE, Madhusudanan P, Shankarappa SA

doi: 10.2147/JPR.S250198.

The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials

Eur J Pain.

Mendoza TR, Dueck AC, Shi Q, Ma H, Zhang J, Qian Y, Cleeland CS

doi: 10.1002/ejp.1139.

Cancer PainNeuropathic Pain

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

Pain.

Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Lo Dico S, Caputo M, Kaasa S, Caraceni A

doi: 10.1097/j.pain.0000000000002076.

Chronic Pain

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Pain.

Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC

doi: 10.1097/

Cancer Pain

ADAM17-EGFR signaling contributes to oral cancer pain

Pain.

Scheff NN, Ye Y, Conley Z, Quan JW, Ronald Lam YV, Klares R 3rd, Singh K, Schmidt BL, Aouizerat BE

doi: 10.1097/j.pain.0000000000001926.

Cancer PainPain ManagementPain Relief

Cancer pain management and the opioid crisis in America: How to preserve hard-earned gains in improving the quality of cancer pain management

Cancer.

Paice JA

doi: 10.1002/cncr.31303.

Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses

Support Care Cancer.

Habberstad R, Hjermstad MJ, Brunelli C, Kaasa S, Bennett MI, Pardon K, Klepstad P

doi: 10.1007/s00520-018-4405-9.

COMMENTED

Cancer PainPain Management

Standards for the management of cancer-related pain across Europe. A position paper from the EFIC Task Force on Cancer Pain

Eur J Pain.

Bennett MI, Eisenberg E, Ahmedzai SH, Bhaskar A, O'Brien T, Mercadante S, Škvarč NK, Vissers K, Wirz S, Wells C, Morlion B

doi: 10.1002/ejp.1346.

Neuropathic Pain

Human induced pluripotent stem cell-derived GABAergic interneuron transplants attenuate neuropathic pain

Pain.

Manion J, Khuong T, Harney D, Littleboy JB, Ruan T, Loo L, Costigan M, Larance M, Caron L, Neely GG

doi: 10.1097/j.pain.0000000000001733.

Related content

Effect of Peritumoral Bupivacaine on Primary and Distal Hyperalgesia in Cancer-Induced Bone Pain

The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

ADAM17-EGFR signaling contributes to oral cancer pain

Cancer pain management and the opioid crisis in America: How to preserve hard-earned gains in improving the quality of cancer pain management

Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses

Standards for the management of cancer-related pain across Europe. A position paper from the EFIC Task Force on Cancer Pain

Human induced pluripotent stem cell-derived GABAergic interneuron transplants attenuate neuropathic pain